US-based company Zeriscope has secured a new army contract to provide assistance in a study that would help mitigate the effects of traumatic brain injury (TBI).
The contract has been awarded by the Army Advanced Medical Technology Initiative (AAMTI).
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Zeriscope is a mobile telemedicine platform company that facilitates live, secure, online, video-enabled telemedicine exams.
The real-time streaming telemedicine platform of the company is being used along with its integrated wearable sensor kit to monitor heart rate variability (HRV), a biomarker associated with the ability to regulate the autonomic nervous system, attentiveness and emotional responses.
Zeriscope’s wearable physiological devices can be used to monitor and study the HRV in out-of-the-laboratory settings.
This will help enhance research and the understanding of treatment options for the critical brain injury that impacts several army personnel who have served the nation in combat zones.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataZeriscope chief executive officer Bill Harley said: “We’re very proud to have been selected by the Army to assist in this important and advanced research on TBI.
“Zeriscope’s easy-to-use and cost-effective telemedicine technology is recognised as a smart solution for a broad variety of innovative telemedicine scenarios, leveraging remote medical experts anywhere, anytime.”
The AAMTI study, which will continue for one year, has been designed to gain more knowledge about the effects of various treatment options that would improve outcomes for the personnel impacted by TBI.
